Clarke Atwell

President & CEO at Claris Biotherapeutics.

Raised on Claris Biotherapeutics filings

$5.6M

of $5.6M offered across 2 Form D filings

Company

Biotech · Jersey City, NJ

Eye drop biologic for neurotrophic keratitis

Eye drop biologic for neurotrophic keratitis

Claris Biotherapeutics Form D filings
Filed	Security	Sold of offered	Filing
Sep 22, 2025	Debt	$2.3M/ $2.3M	Form D
Mar 7, 2025	Debt	$3.3M/ $3.3M	Form D

Also named on Claris Biotherapeutics filings